June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Retinal Vascular Compromise and Increased Astrocyte Density in GC1 Knockout Mice
Author Affiliations & Notes
  • Joseph Holden
    Ophthalmology, Vanderbilt University, Nashville, Tennessee, United States
  • Sarah Al-Awamlh
    Ophthalmology, Vanderbilt University, Nashville, Tennessee, United States
  • Louis-Philippe Croteau
    Ophthalmology, Vanderbilt University, Nashville, Tennessee, United States
  • Andrew Boal
    Ophthalmology, Vanderbilt University, Nashville, Tennessee, United States
  • David J Calkins
    Ophthalmology, Vanderbilt University, Nashville, Tennessee, United States
  • Lauren wareham
    Ophthalmology, Vanderbilt University, Nashville, Tennessee, United States
  • Footnotes
    Commercial Relationships   Joseph Holden None; Sarah Al-Awamlh None; Louis-Philippe Croteau None; Andrew Boal None; David Calkins None; Lauren wareham None
  • Footnotes
    Support  T32EY007135
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 268 – F0313. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Joseph Holden, Sarah Al-Awamlh, Louis-Philippe Croteau, Andrew Boal, David J Calkins, Lauren wareham; Retinal Vascular Compromise and Increased Astrocyte Density in GC1 Knockout Mice. Invest. Ophthalmol. Vis. Sci. 2022;63(7):268 – F0313.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : There is increasing evidence to support a vascular role in the pathophysiology of glaucoma with one element possibly involving insufficient or erratic blood supply to the proximal optic nerve and retina. The α1 subunit of soluble guanylate cyclase (GC1), an enzyme involved in a major pathway of blood flow regulation, has been implicated through human GWAS studies with glaucoma incidence. Because aged GC1 knockout mice exhibit characteristics common to glaucoma, we sought to investigate whether GC1 signaling affected retinal morphology and integrity of the neurovascular unit, which could contribute to the neurodegeneration observed in the model.

Methods : Age-matched 3- or 15-month GC1-/- and WT mice were utilized throughout the study. Using immunohistological staining and fluorescein angiography, we assessed retinal vasculature and astrocytic morphology. We implemented the REAVER analysis tool to quantify multiple blood vessel properties such as length, density, and diameter. We also manually quantified the length of higher-order branches. Custom written code was also used to quantify regional density of GFAP across wholemount retinas as well as assess radial complexity of the GFAP distribution through Scholl analysis.

Results : Aged GC1-/- mice exhibit peripheral retinal vessel dilation compared to WT (33.1 ± 6.1 µm vs. 28.4 ± 6.3 µm diameter; p = 0.015) as well as an increased frequency of shorter capillary branches (p<0.001). There is evidence of blood-retinal-barrier (BRB) breakdown and vessel leakage in aged GC1-/- mice that is absent in age-matched WT mice. GC1-/- mice show aberrant isolectin-B4 staining in a debris-like pattern and increased leakage of fluorescein into the retina by fundus imaging. Retinal vessel compromise coincided with an abnormal morphological astrocyte phenotype; focal regions of GC1-/- retina exhibit a highly disorganized distribution of astrocytes, with areas of dense “matted” astrocytic networks surrounding major blood vessels as well as increased global GFAP-positive density across the retina.

Conclusions : Together our results indicate that dysfunctional GC1-cGMP signaling leads to alterations in retinal vessel and astrocyte morphology with age, which may lead to interruption of blood flow to exacerbate or trigger neurodegeneration. Our results suggest that functional cGMP signaling is important for maintaining the BRB and retinal astrocyte morphology.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×